Overview
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Eligibility
Inclusion Criteria:
- Aged 18 years or older
- Having undergone a CT scan (at the L3 level) prior to treatment
- No severe mental disorder and able to communicate effectively
- Provided written informed consent
Exclusion Criteria:
- Did not provide written informed consent
- Patients deemed unsuitable by the physician